Page last updated: 2024-11-07

androsterone and Diabetes Mellitus, Type 1

androsterone has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment was associated with decreases in testosterone, free androgen index, androstenedione, 17-OH progesterone and estradiol levels."6.78Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus. ( Asenjo, S; Cassorla, F; Codner, E; Eyzaguirre, FC; Iñíguez, G; López, P; Mujica, V; Torrealba, I, 2013)
"Metformin treatment was associated with decreases in testosterone, free androgen index, androstenedione, 17-OH progesterone and estradiol levels."2.78Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus. ( Asenjo, S; Cassorla, F; Codner, E; Eyzaguirre, FC; Iñíguez, G; López, P; Mujica, V; Torrealba, I, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Codner, E1
Iñíguez, G1
López, P1
Mujica, V1
Eyzaguirre, FC1
Asenjo, S1
Torrealba, I1
Cassorla, F1

Trials

1 trial available for androsterone and Diabetes Mellitus, Type 1

ArticleYear
Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus.
    Hormone research in paediatrics, 2013, Volume: 80, Issue:5

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androsterone; Diabetes Complications; Diabetes Mell

2013